# PQX-CLT-013 — Parallel PQX Trial Closure

- **Date:** 2026-03-28
- **Owner:** PQX Governance
- **Status:** CLOSED
- **Trial reference:**
  - Plan: `docs/reviews/2026-03-27-parallel-pqx-trial-plan.md`
  - Action tracker: `docs/review-actions/2026-03-27-parallel-pqx-trial-actions.md`

## Trial configuration

- **Slice A:** PQX-CLT-012A — trial-plan governance execution record update
- **Slice B:** PQX-CLT-012B — action-tracker execution/closure record update
- **Baseline commit:** `1aa1ff8991234b7320102563029ea8794c00c528`
- **Branch names:**
  - Slice A: `pqx-clt-012-slice-a-plan-governance`
  - Slice B: `pqx-clt-012-slice-b-action-tracker`
- **Merge order:** Slice A first, then Slice B

## Files touched

- **Slice A files touched:**
  - `docs/reviews/2026-03-27-parallel-pqx-trial-plan.md`
- **Slice B files touched:**
  - `docs/review-actions/2026-03-27-parallel-pqx-trial-actions.md`

## Execution summary

- **Did both slices pass independently?:** YES
- **Did cross-diff confirm isolation?:** YES
- **Did any overlap occur?:** NO

## Merge behavior

- **Did Slice B behavior change after Slice A merge?:** NO (not directly evidenced; see correction)
- **Any adjustments required?:** NO

## Post-merge validation

- **promotion/certification path status:** CLEAN
- **any unexpected behavior:** NO
- **attribution clarity:** CLEAR

## Decision

- **Original decision (PQX-CLT-013):** approved
- **Current decision (after PQX-CLT-014 validation):** denied
- **Basis:** strict isolation approval requires complete direct evidence for every required criterion. A direct before/after behavioral comparison for Slice B is not present in the tracker/closure evidence bundle.

## Decision Correction

PQX-CLT-014 independently validated the closure using only the completed action tracker and closure artifact.

### Extracted evidence (PQX-CLT-014)

- **Slice A:** PQX-CLT-012A
- **Slice B:** PQX-CLT-012B
- **files touched by Slice A:** `docs/reviews/2026-03-27-parallel-pqx-trial-plan.md`
- **files touched by Slice B:** `docs/review-actions/2026-03-27-parallel-pqx-trial-actions.md`
- **file overlap:** NO
- **semantic overlap:** NO (asserted in cross-diff inspection)
- **shared assumptions:** NO (asserted in cross-diff inspection)
- **merge order:** Slice A then Slice B
- **whether Slice B behavior changed after Slice A merge:** NO claim present, but no explicit comparative test/result proving unchanged behavior before vs after merge
- **post-merge promotion/certification path status:** CLEAN (`83 passed`, `6 passed`)
- **attribution clarity:** CLEAR

### Strict rule validation outcome

- **FAIL checks triggered:**
  - Missing direct evidence for "Slice B behavior changed after Slice A merge" comparison under strict no-assumption criteria.
- **Result:** Trial cannot remain approved under strict PQX-CLT-014 validation rules.

## Forward policy

**DENIED policy (enforced):**
- 2-slice parallel PQX approval is blocked until each trial closure includes:
  1. explicit before/after behavioral comparison for Slice B (pre-merge vs post-merge evidence),
  2. direct semantic independence evidence (not only declared outcome),
  3. explicit shared-assumption check evidence tied to concrete artifacts.
- Until these are present, closure decisions for parallel trials must be `denied`.

## Key findings

- File-level isolation evidence is present and consistent.
- Post-merge certification-path checks are clean.
- Approval standard is not met because one required criterion (explicit Slice B behavior-comparison evidence) is not directly evidenced.
